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Abstract
The PET/CT scanner has been recognized as a powerful diagnostic imaging
modality in oncology and radiation treatment planning. Traditionally, PET has been used
for quantitative analysis, and diagnostic interpretations of PET images greatly relied on a
nuclear medicine physician’s experience and knowledge. The PET data set represents a
positron emitter’s activity concentration as a gray scale in each pixel. The assurance of
the quantitative accuracy of the PET data is critical for diagnosis and staging of disease
and evaluation of treatment. The standard uptake value (SUV) is a widely employed
parameter in clinical settings to distinguish malignant lesions from others. SUV is a
rough normalization of radioactive tracer uptake where normal tissue uptake is unity.
The PET scanner is a sensitive diagnostic method to detect small lesions such as lymph
node metastasis less than 1 cm in diameter, whereas the CT scanner may be limited in
detecting these lesions. The accuracy of quantitation of small lesions is critical for
predicting prognosis or planning a treatment of the patient. PET/CT uses attenuation
correction factors obtained from CT scanner data sets. Non-biological materials such as
metals and contrast agents are recognized as a factor that leads to a wrong scaling factor
in the PET image. We challenge the accuracy of the quantitative method that physicians
routinely use as a parameter to distinguish malignant lesions from others under clinical
settings in commercially available CT/PET scanners. First, we verified if we could
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recover constant activity concentration throughout the field of view for small identical
activity concentration sources. Second, we tested how much the CT-based attenuation
correction factor could be influenced by contrast agents. Third, we tested how much
error in quantitation could be introduced by object size.
Our data suggest that the routine normalization process of the PET scanner does
not guarantee an accurate quantitation of discrete uniform activity sources in the PET/CT
scanner. Also, activity concentrations greatly rely on an object’s dimensions and object
size. A recovery correction factor is necessary on these quantitative data for oncological
evaluation to assure accurate interpretation of the activity concentration. Development of
parameters for quantitation other than SUV may overcome SUV’s inherent limitations
reflecting patient-specific physiology and the imaging characteristics of individual
scanners.

vi

Chapter 1
Introduction

1.1 Motivation
The hybrid system of a PET scanner combined with CT scanner (PET/CT) has
gained popularity in the oncological community since its commercial introduction to the
market in early 2001 [1]. The integrated PET/CT unit superimposes PET images on CT
images with minimum co-registration problems between the two images by minimizing
patient movement. Simultaneously providing anatomical information by CT scan helps
physicians to identify the anatomical location of the lesion demonstrated on the PET
images [2]. Integrated PET-CT has been shown to improve accuracy of the staging in
cancers, such as lung cancer [3, 4] and head and neck cancer [5]. Another uniqueness of
the PET/CT scanner is that the CT numbers gained from the CT data sets are converted
into attenuation correction factors to correct images in the PET data sets.
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Traditionally PET has been employed to differentiate benign lesions from
malignant lesions and for staging of malignancy as a diagnostic modality [6-8].
Currently, the advantage of the PET/CT in radiation treatment planning (RTP) has been
recognized because of its ability to demonstrate a tumor’s physiological information. In
RTP the target volumes are contoured and a dose is prescribed to these lesions. The
PET/CT information potentially changes tumor target volume in the treatment planning
[9]. Therefore, the quantitative accuracy of the PET/CT scanner is an issue.
2-deoxy-2-[18F]-fluoro-D-glucose (18F-FDG) PET/CT has been used as a
radioactive tracer for imaging of brain, heart, and tumor diagnosis.

18

F-FDG is an analog

of glucose (Figure 1-1). This tracer is injected into a patient intravenously and is
transported into the cells mainly by the glucose transporters, GLUT1 and GLUT4 and
phosphorylated by hexokinase, a rate limiting enzyme of glucose metabolism (Figure 12).

18

F-FDG-6-P, a phosporylated 18F-FDG metabolite is negatively charged and cannot

leave the cell, where it accumulates. With PET, we can visualize 18F-FDG-6-P trapped
into the cells of various tissues [10]. Cancer cells have a higher glycolysis rate compared
to the tissue in which it arose. Increased 18F-FDG uptake of the hypoxic cell reflects that
these cells require more glucose uptake to support anaerobic glycolysis, mediated by an
increase in expression of glucose transporters in the cell membrane. 18F-FDG uptake does
not directly reflect tumor-specific glucose metabolism.18F-FDG uptake can occur in other
glucose utilizing cells such as macrophages and leukocytes that are rich in inflammatory
tissue and may cause a false positive study in PET. A recent histopathological study of
18

F-FDG uptake showed that 18F-FDG is selectively demonstrated within viable and

hypoxic cells in vivo [11]. This study indicates that PET has a potential to distinguish
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hypoxic cell groups, which are more resistant to radiation therapy and more likely to be a
source of distant metastasis or recurrence in the future. This suggests a unique role for
PET in oncology treatment planning by distinguishing more resistant cell groups from the
others; using PET for targeting with narrow beam intensity modulated radiation therapy
can potentially deliver higher dose selectively to the more radiation resistant volume.
Imaging with 18F-FDG is not the only radiopharmaceutical in the application of
PET in oncology. 3’-deoxy-3’-[18F] fluorothymidine (FLT) assesses tumor proliferation.
FLT is uptaken by cells and phosphorylated by thymidine kinase 1. Images of FLTmonophosphate trapped in the cell reflect the thymidine kinase activity, which also is a
measure of the rate of tumor proliferation. Knowledge of the patient’s specific tumor
proliferation potentially changes the fractionation schedule of radiation therapy [9].
One of the widely used quantitative parameter to distinguish malignant from
benign lesions is standard uptake value (SUV), defined as:
SUV =

Tracer uptake ( MBq / mL )
.
Administer ed activity ( MBq ) / ( patient weight (kg ) × 1000)

(1)

The tracer does not distribute evenly throughout an entire patient’s body. Normal SUV is
by definition under this model roughly equal to one. Malignant lesions have higher
glucose metabolic rates compared to the normal tissue with SUV’s usually ranging from
4 to 15 [12]. A region of interest (ROI) is drawn by a physician and maximum, minimum,
and average SUV are displayed on the image according to the software setting of the
scanner. The maximum SUV particularly has diagnostic value, because (1) its value is
independent of the lesion’s area drawn by a person and (2) tumor lesions have
heterogeneous SUV values, therefore we are most concerned with the highest metabolic
rate.
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Our question is: “How reliable are these SUV values?” PET scan images use gray
scale maps to depict activity concentrations of a positron emitting source in the body. We
decided to investigate major factors that can adversely alter SUV. The normalization
process to an individual patient in Equation 1, where one divides by uniform distribution
of the normal tissue, causes more error. Each individual has different metabolism of the
tracer. Distributions of the activity concentration reflect an individual’s physiological
function. Therefore, we ignored the denominator of Equation 1 and only concentrated on
activity concentrations (the numerator) that are utilized to calculate SUV.
Many factors affect quantitative accuracy of the PET/CT; some are particularly
unique to hybrid PET/CT scanners [1, 13, 14]. The scaling problem of attenuation values
(µ) at 70 keV into 511 keV is an inherent problem for the PET/CT unit. The µ is an
energy-dependent value. The attenuation correction factors are obtained from a CT scan
at a mean energy of 70 keV and scaled into a µ at 511 keV by a manufacturer-dependent
algorithm [1].
One problem is oral and intravenous iodinated contrast materials are commonly
used in CT. They enhance attenuation in the gastrointestinal tract and in vessels to assist
visual discrimination of these anatomic structures. This contrast can create artifacts in
both the CT image and CT-based attenuation correction of the PET image [15-17].
Partial volume effect is another factor that affects quantitative analysis in PET.
The volume of the object, relative to the spatial resolution of the imaging system, affects
the recovery of activity concentration of PET and single photon emission computed
tomography (SPECT). This effect has been discussed extensively for PET and SPECT
brain research studies [18]. It is critical in a malignancy, such as glioblastoma
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maltiforme, where a physician is interested in whether recurrent tumor is present
compared to the normal cortex. We noticed that this partial volume effect of the
PET/CT scanner is not widely considered when it comes to image interpretation in
oncology settings.
Another issue that we did not cover in this thesis is organ movement.
Physiological activity such as respiration, heart beat, and bowel movement are
problematic [13, 19, 20]. Sometimes anatomical location of the lesion is disregarded
because of artifacts created by physiological motion. Diagnosis of the patient with
lesions at the base of the lung and the dome of the liver is particularly difficult. To solve
respiratory motion, respiratory-gated PET scanning is under research development [21,
22].
Physicians are advised to review two sets of fused PET/CT images, using both
attenuation corrected PET and non-attenuation corrected PET images [13]. One of the
issues that PET/CT is facing is that this diagnostic area lies at the interaction of nuclear
medicine physicians, radiologists, and radiation oncologists. Well-trained nuclear
medicine physicians can make reasonable judgments whether a lesion is malignant or not
from these two sets of data. However, most manufacturers do not routinely fuse nonattenuation corrected PET images to CT image data sets.
A goal is to use PET/CT scanners as a method of quantitative evaluation
reflecting the biological behavior of the tumor. The accuracy of these quantitative values
is critical to the target. A decision made about a patient’s treatment causes tremendous
effects on his or her quality of life. We were very curious in the clinical setting if the
default PET/CT image reconstructions were sufficient to overcome attenuation correction
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artifacts mentioned above and also the partial volume effects. Further, we search to
understand the limitations of PET/CT in the clinical settings.

1.2 Organization of the Thesis
Chapter 2 describes basics of PET/CT physics and instrumentation to understand
the performance of the scanners. Chapter 3 describes the performance of the PET/CT
scanner we tested including counting-rate characteristics and uniformity of response.
Chapter 4 discusses the effect of contrast agents on attenuation-correction accuracy.
Chapter 5 describes an investigation of partial volume effects and possible methods to
recover activity concentrations. The final chapter provides a summary of the work and a
brief discussion of potential future research directions.
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Figure 1-1: Structure of [18F]-fluoro-2-deoxy-D-glucose
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Figure 1-2: 18F-FDG metabolism and intracellular accumulation. Adopted from Thrall
JH. et al. Clinical Molecular Imaging. ACR-ASTRO 2003 Molecular Imaging
Conference

7

Chapter 2
Related Physics

2.1 Instrumentation and Physics of PET/CT
Scanner
2.1.1 Positron Decay
Many proton rich radionuclides decay via positron emission into a more stable
state. A proton is converted into a neutron, a neutrino, and a positron.
+

1p

ZX

→
→

0n

+ 1β+ + ν

Z-1Y

(2)

+ 1β+ + ν

A positron is the anti-matter of an electron. The positron emitted from the nucleus will
lose kinetic energy by interactions with the surrounding matter. The path is deflected
from its original path by any of four types of interactions: inelastic collisions with atomic
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electrons, elastic scattering with atomic electrons, inelastic scattering with a nucleus, or
elastic scattering with a nucleus. The positron takes a torturous passage through matter,
which complicates the estimation of range. Eventually, the positron and an electron may
form a metastable intermediate species, positronium. The electron and positron revolve
around their center of mass; positronium’s half-life is about 10-7 seconds. The
positronium formation occurs in about one-third of cases in water or human tissue while
direct annihilation occurs the rest of the time [23].
When the positron and electron annihilate, they give off electromagnetic radiation.
The most probable mode is rest mass converted into two photons of 511 keV each,
propagating at 180 degrees to conserve momentum when the positronium has no residual
kinetic energy (Figure 2-1). This principle is used to determine the line of response in the
PET scanner. At less than 1% probability, three photons can be emitted. Also, not all
annihilation events are zero-momentum; to safisfy momentum-conservation, these photon
pairs are not exactly emitted at 180 degrees (a maximum deviation of ±0.25 degrees)
[24]. In water, about 65% of annihilations deviate from co-linearity. This effect
contributes resolution blurring of 1.5 mm to 2.0 mm for 80 cm to 90 cm diameter PET
rings [23, 24].
There are several nuclides used in PET:
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C (T1/2: 20.3 min, max range in water:

5.4 mm) 13N (9.97 min, 5.4 mm)), 15O (124 sec, 8.2 mm), and 18F (110 min, 2.4 mm).
18

F-FDG is the predominantly used radionuclide for PET imaging because of its

relatively long half life.
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Nucleus
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e-

∆θ

γ (511keV)

positronium
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Positron
Decay

180 degrees

γ (511keV)

Figure 2-1: Illustration of positron decay and annihilation photons. The positron takes a
torturous passage through matter and interacts with an electron. A metastable species,
positronium, is formed about one-third of the time in water. Upon annihilation, the rest
mass is usually converted into two photons of 511 keV at 180 ± 0.25 degrees.

2.1.2 Photon Interaction in Matter
Among photon interactions -- coherent scattering, photoelectric effect, Compton
scattering, and pair production -- photoelectric effect and Compton scattering are
particularly important in PET imaging physics. For soft-tissue and bone, the total
attenuation coefficients are dominated by photoelectric absorption in the photon energy
range below 100 keV and dominated by Compton scattering in the photon range of 2001000 keV [25].

• Photoelectric effect
Photoelectric effect dominates in human tissue at energies less than 100 keV. The
fact is important for PET/CT scans that use CT data for attenuation correction. Mean CT
photon energy is at 70 keV. The mass attenuation coefficient for photoelectric absorption
is approximately:

µ Z 4.5
∝ 3
ρ
E

(3)

for photon energies from 10 keV to 500 keV and atomic numbers from 1 to 92.
10

• Compton Scattering
Compton scattering is directly proportional to Z and inversely dependent on
photon energy from 10 – 1000 keV. Monte Carlo simulation of the interaction of
annihilation photons with tissue-equivalent material in PET shows that more than 80
percent of scattered events that are detected have undergone only a single scattering
interaction [23].

2.1.3 Photon Spectrum
PET images are based on detecting monoenergetic photons (511 keV) produced
by annihilations. X-ray tubes produce a continuous bremsstrahlung spectrum which also
contains characteristic X-rays with discrete energies corresponding to the transitions of
orbital electrons in the high-Z target material, typically tungsten (Figure 2-2).

X-ray
source

Intensity
I0(E)
0

30

Positron
Source

120

E (keV)

511

Spectral distribution

Figure 2-2: Photon energy spectral distribution for x-ray source and positron source [25].

Low energy photons are absorbed in matter by photoelectric absorption, shifting
the average spectral energy to the right. This beam hardening effect causes significantly
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undesirable effects on X-ray imaging because it introduces image contrast variations
depending on the photon paths in addition to the object attenuation properties.
An X-ray CT detector operates in charge-integration mode and does not have
energy discrimination, unlike a nuclear medicine detector. PET detectors operate in
single-photon counting mode and have energy discrimination, ideally allowing rejection
of scattered photon counts.

2.1.4 True, Random and Scattered Events
• True and Random Events
To be considered a valid event, the PET scanner must detect two 511 keV events
simultaneously in two different detectors (Figure 2-3). The system assigns a line of
response (LOR) for coincidence events, a straight line connecting the two detectors.
Ideally, the positron annihilated somewhere along this LOR.

*

Annihilation event
Annihilation photon
Assigned LOR

*

True
Coincidence

*

Scattered
coincidence

Figure 2-3: True, scattered, and random events
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*
*

Random
coincidence

The difference in time window (Figure 2-4) is set under consideration of the
following factors: time of travel of two annihilation photons, the detector’s scintillation
time, and the electronics’ processing time. The scintillation time affects the time
resolution, which is the uncertainty in the timing characteristics due to fluctuation of
scintillation decay. A detector with short scintillation time constant has a small timing
resolution. The maximum difference for time of travel by each photon before interaction
in the detectors is about 3.33 ns using speed of light (3x108 m/s) and for a 1 meter scanner
diameter. At time T, if detector 1 produces a signal, then any signal produced by detector
2 between T+τc and T-τc is considered a coincident event. The resolving time of the
circuit is the coincidence time window and expressed as 2 τc.
Random events occur when photons from different annihilations reach the
detector within the coincidence time window. If S1 and S2 are singles count rates on
channel 1 and 2 (counts/second), the random (R) events can be expressed as follows.
R12 = 2 ⋅ τ c ⋅ S1 ⋅ S 2

(4)

For example, for a typical bismuth germanate Bi4Ge3O12(BGO) scanner, the coincidence
time window is set to 12.5 nsec.
Signal B

V2

t2

Detector A
V1

Signal A

t1

time

Detector B

time
Signal A
Signal B
Coincidence
window

2T
t1

t2

time

Valk PE et. al. Positron Emission Tomography. Springer 2002

Figure 2-4: Illustration of the coincidence true window. Signal B is in coincidence with
signal A if it occurs any time within the coincidence time window.
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From this equation, the total random rate is approximately proportional to the
square of total count rate for all detector pairs. To minimize random coincidences, one
can decrease the coincidence window; however this introduces statistical error due to
event triggering fluctuation. The use of fast scintillators [decay constant - GSO: 60 nsec,
lutetium oxyorthosilicate doped with cerium Lu2SiO5 (LSO): 40 nsec] can reduce the
time window. However, it can not be reduced more than the time-of-flight (3-4 nsec) that
is set by the scanner diameter. The optimal window is typically set to 3-4 times the full
width at half maximum (FWHM) timing resolution of the PET scanner. The typical
coincidence time window is 12 ns for BGO-based systems and 8 ns for GSO and NaI(Tl)based systems.
All coincidence events are called prompt events and are expressed as
Prompts (P) = trues (T) + scatters (S) + randoms (R)

T = P−S −R

(5)

By using this formula (4) and (5) with known S1 and S2, random events can be removed
statistically from prompts. However, randoms correction process results in propagation
of noise in the data set; therefore the best solution is to reduce random events either by
reducing the count rate or by using a smaller coincidence time window. This is the reason
why a PET scanner with good timing resolution is desirable.

• Scattered Events and Energy Windows
A certain portion of photons created in the body will interact in the body either by
photoelectric absorption or Compton scattering. A Compton-scattered photon propagates
in a different direction than the original unscattered photon. Coincidence events due to
scattered photons cause misinterpreting of LORs and misrepresenting the true activity
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distribution within the image (Figure 2-3). This causes blurring in the image, therefore it
is important to remove these events.
Scatter is an especially important component of the signal in 3D imaging
compared to 2D imaging where scatter contributes only a minor part of the signal [26].
In 3D imaging the calculated activity count rate is modified as follows:
⎡
⎛ S scattered
A ∝ ⎢ P − ⎜⎜ scatter
⎝η
⎣

⎤
⎞
⎟⎟ − R ⎥ × AC × DT × η true
⎠
⎦

AC:

attenuation correction factor (See Chapter 3)

DT:

dead time correction

ηtrue:

normalization coefficient for scattered coincidence

ηscatter:

normalization coefficient for true coincidence

(6)

S scattered : scattered count rate

There are several efforts to approximate these normalization coefficients. Unfortunately,
the scatter normalization coefficient is not a unique value (it depends on scattering angle).
However, variation in scatter normalization coefficients is probably negligible compared
to the scatter estimate itself.
Ideally, we should set the energy window exactly at 511 keV to reject all
scattering events. This cannot be done for real PET scanners: scintillation crystals have a
limited energy resolution; setting the energy window too wide will accept too much
scatter, degrading image quality. If we set the energy window too narrow, it will reject
some true events. Commercial PET scanners use wide energy windows to achieve high
sensitivity, at the expense of accepting some scattered events. NaI(Tl) based scanners
have good energy resolution (10–15%) and the energy window is set from 435 keV to
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590-665 keV. BGO crystals have worse energy resolution compared to NaI(Tl) crystals.
A typical BGO scanner’s energy window is set from 300-350 keV to 650 keV. [24].
One of the methods to reduce scattering events is use of lead or tungsten septa (i.e.
2D mode). In multi-ring scanners, septa reduce scattered photons reaching the detectors.
Septa also reduce the sensitivity of the scanner. Another method is to mathematically
correct scattering events by using object-scatter models; however, scatter is very objectdependent. Currently, simple but computationally efficient models are used, but these are
inherently limited in their accuracy. Monte Carlo methods can provide more realistic
models but are too computationally intensive for clinical practice; recent developments of
acceleration techniques eventually may make Monte Carlo methods feasible for clinical
practice [27].

2.1.5 Sensitivity and Depth of Interaction
The sensitivity of a PET scanner is determined by its geometry and detector
stopping power. The ideal geometry of PET scanners is (1) a small diameter and large
axial field of view (FOV), and (2) a scintillation detector with high stopping power and
high energy resolution. After a photon enters the detector, it travels a short distance
before depositing its energy. Typically, the event registers the LOR as a connection of
two points on the entrance surfaces of the detectors rather than the two actual interaction
points. The error from this assumption becomes large when the photons enter at an
oblique angle and with thick detectors. This parallax error is worst when annihilation
occurs in the periphery of the scanner’s FOV. The thickness of the detector trades off
sensitivity and stopping power with parallax error. Detectors providing depth-ofinteraction measurement are under research, e.g. [28].
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2.2 Photon Attenuation and Attenuation
Correction Factors
2.2.1 Attenuation Correction Factors
Suppose the scanned body consists of a homogeneous material, and d1 and d2 are
the distance each annihilation photon traveled through the tissue (Figure 2-5). Then the
probability of uncollided photons emitted along line D escaping from an object is given
by

P = exp(− µ ⋅ d1 ) ⋅ exp(− µ ⋅ d 2 ) = exp(− µ ⋅ (d1 + d 2 ) = exp(− µ ⋅ D )

(7)

d2
d1

D
Constant µ511

ACF = exp(+ µ ⋅ d1 + µ ⋅ d 2 ) = exp(+ µ ⋅ D )
Uncollided photons emitted from the object along line D = N 0 ⋅ exp(− µ ⋅ D )
Uncollided photons emitted from the object along line D × ACF = N 0 ⋅ exp(− µ ⋅ D ) ⋅ exp(+ µ ⋅ D ) = N 0

Figure 2-5: Attenuation correction factor in homogeneous material
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If the attenuation coefficients along the LOR are not uniform (Figure 2-6), then the
relation becomes
⎛ x
⎞
⎛ l
⎞
⎛ l
⎞
P = exp⎜ − ∑ µ1i ⋅ d1i ⎟ ⋅ exp⎜ − ∑ µ 2i ⋅ d 2i ⎟ = exp⎜ − ∑ µ i ⋅ d i ⎟
⎝ i =o
⎠
⎝ i=x
⎠
⎝ i =0
⎠

(8)

N 2 = N 02 ⋅ exp(− Σµi ⋅ d 2i )
d2
d1

D

N1 = N 01 ⋅ exp(− Σµi ⋅ d1i )
Figure 2-6: Attenuation correction factor in heterogeneous material.

We know that for each LOR the ratio of I0 (blank scan) to I (acquired transmission scan)
is
I0
⎛ l
⎞
= exp⎜ ∑ µ ⋅ d i ⎟
I
⎝ i =0
⎠

(9)

The factors to correct non-uniform attenuation correction coefficients are called
attenuation correction factors (ACFs) and they are obtained from transmission scans.
Widely-used attenuation correction factors are obtained using (1) positron sources, (2)
gamma-ray sources, and (3) x-ray sources (Table 2-1). If we use an emission source
other than a positron emitter, we must re-scale the attenuation correction factors since the
attenuation coefficients are energy dependent. There are three methods for emission
scans: (1) positron sources: 68Ge/ 68Ga [β+ emitter (511 keV annihilation photon),
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transmission data from coincidence events]; (2) γ-ray Sources: 137Cs [a γ emitter (662
keV) and single events are collected as a transmission scan. The attenuation correction
factors obtained are at 662 keV, not at 511 keV, and require scaling down. Both scaling
and segmentation methods were used for this correction]; (3) CT sources, which describe
next.

• CT Sources
There are four advantages of using CT scan for transmission scans: (1) lower
statistical noise compared to the radionuclide sources, (2) faster acquisitions, (3) no
contamination from emission photons, (4) it does not require periodic replacement of
positron sources, and (5) CT with PET can be used to localize activity in relation to
anatomy. The disadvantage of using CT scan for ACFs is that it requires re-calculation
of ACFs at 511 keV from attenuation coefficients obtained from 30-140 keV spectrums
by CT scans. There are three conversion methods: segmentation, scaling, and dualenergy CT scans.

Table 2-1: Comparison of the transmission methods for PET [25].
Sources

positron

single gamma

X-ray

Photon energy (keV)
Patient scan time (min)
Transmission noise
Potential for bias/artifacts

511
15 - 30
highest
low

662 for Cs-137
~ 5 - 10
high
some

continuous:~30 to 140
~1
insignificant
highest

• Segmentation
Segmentation classifies CT images into different tissue types (such as soft tissue,
lung, and bone). Then CT values are changed to corresponding attenuation coefficients
at 511 keV. A problem arises when the tissue changes value continuously (in the lungs,
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up to 30%); replacing by a single attenuation coefficient at 511 keV potentially
introduces an error [25].

• Scaling
The images created by CT are approximately linearly correlated to the attenuation
coefficients of soft tissue. CT values multiplied by the ratio of the attenuation
coefficients at 511 keV and at mean CT energy are called scaling [1, 25]. For low-Z
material, the approximation of the attenuation coefficient is accurate when multiplied by
scaling factors. However, different scaling factors are necessary for bones, because
linear scaling is a poor approximation. This is because the high Z value of calcium
(Z=20) leads to higher photoelectric attenuation coefficients at CT energies.
Another method, called the “hybrid method” is a combination of scaling and
segmentation (Figure 2-7). This separates bone and non-bone components and then uses
separate scaling factors for each component. There is a discontinuity at 300 HU. The
“bilinear method” is piece-wise continuous [25]. Although both the hybrid and bilinear
methods give reasonable approximations for biological materials, in the presence of
contrast materials and metal objects, the approximations are still inaccurate.

• Dual Energy X-ray Imaging
By scanning two or more spectra of an x-ray beam, CT numbers can be converted
into 511 keV linear attenuation coefficients as a weighted sum of photoelectric absorption
and Compton scattering. The problem of this method is errors caused by image noise.
CT scan is not the only-method to map attenuation coefficients throughout the
body. For instance, T1-weighted magnetic resonance imaging (MRI) has been
investigated for attenuation and scatter correction in 3D brain PET imaging [29].
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Figure 2-7: Conversion of CT numbers to linear attenuation coefficients at 511 keV. The
hybrid method has a discontinuity at 300 HU and the bilinear method has a change in
slope at 0 HU [25].

2.2.2 Problems for CT-based Attenuation
Correction
A mismatch of calculated and true attenuation coefficients introduces biases and
artifacts in the reconstructed PET images.

• Spatial Mismatch
CT scans are usually obtained at end-inspiratory phase as opposed to PET scans,
which are obtained as respiratory-averaged images. This causes spatial mismatches. One
of the solutions is to acquire CT images during the partial expiratory phase to match with
the PET emission images under the sacrifice of diagnostic quality of CT images.
Respiratory gating and motion tracking devices are under investigations [21, 22].

• Truncation Artifacts
PET scanners often have larger FOV (50-70 cm) than a CT scanner’s FOV (45-60
cm). PET scans are often obtained with the patient’s arms next to the body while the
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arms may be raised during the CT scan. For a large patient, some part of the body may
be outside the CT’s FOV, resulting in some bias of the reconstructed activity distribution
due to erroneous ACFs [13].

• Metal Implant
Many oncological patients have metal implants such as chemotherapy ports,
pacemakers, dental fillings, and artificial joints. These high-Z materials cause significant
artifacts in the attenuation correction factor obtained in the CT energy range. It is
especially important to reconstruct attenuation uncorrected images in these patients.

• Contrast Agents
Intravenous (IV) contrast agents are composed of iodine (Z=53) at concentrations
of 300-380 mg/mL. Typically, 100-200 mL of IV contrast agent is injected as a bolus at
a rate of 1.5 to 5 mL/s [25]. The distribution of contrast agent depends on the time after
injection. Over time, the agent is excreted through the kidneys, ureters, and bladder.
Oral contrast agents are either barium (Z = 56) based or iodine based. Because of
increased attenuation due to high Z, these contrast agents produce contrast in a CT image.
Immediately after a bolus injection, the CT numbers of highly vascularized tissue
increase to 200-300 from 30-60. At 511 keV the mass attenuation coefficient of iodine is
about the same as water or soft tissue (Figure 2.8). Therefore, any scale factor that
correctly predicts the attenuation factor at 511 keV for bone or soft tissue will
overestimate the attenuation at 511 keV for contrast agents [25]. According to recent
literature, intravenous contrast at normal concentrations has little effect on the CT-based
ACFs, but for oral contrast, larger intestinal volumes and a wide range of concentration
(about 170 HU in the stomach, about 700 HU in lower gastrointestinal tract where water
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is absorbed) can potentially cause overestimation of ACFs [1]. A recently-proposed
approach to avoid over-estimation of ACFs is, for pelvic gastrointestinal oral contrast
agent, the use of negative oral contrast agent [13].

Figure 2-8: Comparison of scaling of attenuation coefficients. (a) The mass attenuation
coefficient is significantly enhanced at CT photon energies for iodine, but at 511 keV it is
similar to other materials. (b) Comparison of the linear attenuation coefficient at 511
keV vs. CT numbers predicted with the true value for iodine. [25]

2.3 Image Reconstruction Algorithms
2.3.1 Overview of Reconstruction Algorithm
PET data is acquired in either 2D or 3D mode. The 3D mode requires more
memory and more computational time. Filtered-backprojection algorithm (FBP) is a
classical analytical reconstruction algorithm widely used for computed tomography. In
contrast to analytical algorithms, iterative algorithms assume a statistical distribution of
the data is derived from a Poisson model. Recent developments of fast iterative
algorithms allow more accurate reconstruction of acquired data. The ordered subset
expectation maximization (OSEM) algorithm in 2D mode is widely used in commercial
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PET/CT scanners. 3D iterative reconstruction is independent of geometry, but it is
computationally intensive. Hybrid algorithms combine efficient 2D iterative algorithms
with a fast rebinning algorithm, where 3D data is reduced into 2D data.

2.3.2 2D Data
• Analytic 2D Reconstruction
The Radon transform of an object f (x, y ) , denoted as g (s, φ ) , is defined as its
line integral along a line inclined at an angle φ from the y-axis and at distance s from the
origin.
Mathematically, it is written as

g (s, φ ) ≡ ℜf ( x, y ) = ∫

∞

∞

∫ f (x, y )δ ( x cosφ + y sin φ − s)dxdy

−∞ −∞

(10)

where ℜ is the Radon transform operator.
In medical imaging, we are interested in recovering f (x, y ) from the sinogram g (s, φ ) ,
which is the measured PET data, after corrections for scatter, randoms, and attenuation.
Associated with the Radon transform the back-projection operator is defined as
π

b(x, y ) ≡ Βg (s,θ ) = ∫ g ( x cos φ + y sin φ , φ )dφ
0

(11)

The reconstructed image
~
f ( x, y ) ≡ Bg = Bℜf

(12)
1

is f ( x, y ) blurred by the PSF

(x + y )
2

2

1
2

.
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During reconstruction, filtering or deconvolution is used to remove the PSF blurring,
recovering the original object f(x, y). Details of the FBP reconstruction methods can be
found in imaging textbooks [30, 31].

• Iterative Reconstruction
Filtered backprojection is computationally efficient. It is based on the assumption
that the projection images are perfect projections of a three dimensional object. This is
not true: Compton scattering, and photon attenuation factors in the patient affect the
LORs. Iterative reconstruction has been developed to overcome this problem. An initial
activity distribution in the patient is assumed, and then projection images are calculated
from the assumed activity distribution. The calculated projection images are compared
with the actual images and the assumed activity distribution is modified and recalculated
[32].
The most widely used iterative algorithms in PET are the maximum-likelihood
expectation maximization (ML-EM) algorithm and its accelerated version OSEM.
OSEM was proposed in 1994 and is sufficiently fast for clinical applications. With each
iteration, the target function is updated several times, proportionally accelerating
convergence. An optimization of subsets and iterations is required when the method is
applied to real noisy data. The detail of the algorithm is explained elsewhere [23, 24].

• 3D Analytical Reconstruction by Rebinning
Reconstruction of 3D PET data requires large amounts of memory due to the
large number of LORs. Strictly, 2D mode produces N sinograms. In practice, in a multiring system, we allow cross-slices and having 2N-1 detector rings. A full 3D mode
produces N direct transaxial slices and N (N-1) oblique sinograms (N2 in total).
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Rebinning is a method to estimate 2D transaxial sinograms from oblique sinograms
acquired in 3D mode. Two rebinning approaches are commonly used: single-slice
rebinning (SSRB) and Fourier rebinning (FORE) [23]. SSRB assumes that each
measured oblique LOR only traverses a single transaxial section within the support of the
tracer distribution and average overall available estimates. SSRB induces axial blurring
and transaxial distortions because of its approximations. FORE is more accurate than
SSRB. Fourier transforms and normalization are used to rebin the data according to septal
frequency information After inverse 2D Fourier transform, the rebinned transaxial slices
are obtained. This algorithm assumes that the data are line integrals of the tracer
distribution and each oblique sinogram is sampled fully. FORE is sufficiently accurate in
practice when the axial aperture is less than 20 degrees [23].
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Chapter 3
Uniformity of Activity Concentration of
Discontinuous Positron Emitting Sources

3.1 Instrumentation of PET/CT Scanners
3.1.1 True, Scatter, and Random Events and Energy
Window
In a clinical PET/CT exam, approximately 10 mCi 18F-FDG is injected
intravenously into the patient. It is important to understand how the physical
performance of the PET/CT scanners produces the observed image quality. To assess the
performance of the CTI-Siemens PET scanner, we recorded true, scattered, and random
coincidence events for different activity levels. Energy windows are set by the
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manufacturer and we do not have equipment to test the energy window width directly in
our facility.

3.1.2 Materials and Methods
Data in this study was acquired with a CTI-Siemens Reveal-HD (Knoxville, TN). The
acquisition and reconstruction protocols use the following manufacturer’s settings (Table
3-1).

Table 3-1: Acquisition and reconstruction parameters of CTI-Siemens Reveal-HD.
F-18 half-life (sec)
Sinogram dimensions
matrix size [1]
matrix size [2]
matrix size [3]
Scale factor (mm/pixel) [1]
Scale factor (mm/pixel) [2]
Scale factor (mm/pixel) [3]
Holizontal bed translation
Axial compression
Maximum ring difference
Number of segment
Total number of sinogram
Lower energy window (keV)
Upper energy window (keV)
Number of rings
Axial FOV (cm)
TransverseFOV (cm)
Scintilation Cristals
Number of PMTs
Total number of block bucket
Number of image planes

6586.2
3
228
228
239
2.25
1
2.425
stepped
9
22
5
239
350
650
32
15
66
BGO
576
96
47

A 18F-FDG source was drawn into 5mL syringes and the activity was measured with a
well counter (CRC-15R, Capintec, Inc., Ramsey, NJ). Each syringe was placed at the
center of a cylindrical acrylic phantom with 20 cm diameter. The center of the phantom
was aligned to the center of the FOV using the PET/CT scanner’s laser indicator. For
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each source, true, scatter, and random events were recorded. Emission data were
scanned using default settings for a thoracic scan (Thorax C-A-P + C) with one PET bed
and a 5-minute acquisition time. Images were reconstructed with OSEM4i8s (4 iterations
8 subsets) with 128x128 matrix and FORE 3D sinogram rebinning. ACFs were obtained
from helical CT scan data with parameters of 120 kVp, 80 mA, 0.8 s per CT rotation, 3 s
delay, 83 sec scan time.

3.1.3 Results and Discussions
For 18F-FDG, our scanner demonstrated a linear relation between activity
concentration and singles counts for activity less than 10 mCi (Figure 3-1). True counts
(coincidence events) were saturated approximately at 2 mCi with 1.7 x 106 counts/second
(cps).
In the clinical patient setting, the recommended dose for a 70 kg adult patient is 510 mCi. The typical dose given to an adult patient for a whole body PET scan is 10 mCi.
A patient fasts for 4-6 hours prior to the injection. After injection, the patient rests for
45-60 minutes; before the PET/CT scan, the patient is asked to void the bladder. The
amount of 18F-FDG in the bladder depends on many factors including the patient’s renal
function. In the literature it is documented that approximately 20% of 18F-FDG is
discovered in the urine at 2 hours after the injection [33]. FDG’s half life is 110 minutes.
A rough estimation without considering attenuation and distribution of the tracer in the
body is
⎛
⎛ 60 ⎞ ⎞
A(60 min) = A0 • exp⎜⎜ − ln 2 • ⎜
⎟ ⎟⎟
⎝ 110 ⎠ ⎠
⎝
If A0 = 10 mCi, then after A(60 min) = 6.85 mCi.
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(13)

Approximately 20% of 18F-FDG appears in the bladder. The remaining activity in
the body is about 6 mCi at the time of scanning. Typical whole body PET uses 6 bed
positions. Ignoring the lower body, the rest of the body is about 4 PET beds. Then
neglecting the scattering from outside of FOV, approximately 1.5 mCi of activity is
located in one PET bed. Comparing to Figure 3-1, a 10 mCi dose is likely to be under
saturation of the PET scanner’s true counts.
As described in the instrumentation section, BGO crystals have good stopping
power, but poorer light yield and resolution than NaI(Tl) crystals. BGO crystal’s energy
resolution is 25%; LLD is set to 350 keV; and ULD is set to 650 keV. A 3D PET scanner
does not have septa between the BGO crystals. A 3D mode acquisition improves
statistics by increasing the number of counts, but at the expense of increased scattered
and random events.
Accepting more counts has an advantage for patients by reducing tracer activity
and reducing acquisition time. However, 3D mode image reconstruction is
computationally intensive. Furthermore, the 3D mode suffers from blurring of images by
accepting more scattering events as true counts. This problem is not only from inside of
FOV but also from outside of the FOV. This may cause problems in image quality:
organs located outside of FOV with high 18F-FDG concentration such as brain or bladder
possibly contribute scattered events into the FOV.
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Figure 3-1: Relation between the activity (in 5mL syringe) at the center of the field of
view and the measured true, random, and single counts. The source was 18F-FDG.
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3.2 Uniformity of the Radioactivity Concentration
3.2.1 Normalization and Uniform Activity
Concentration source
In PET instrumentation the best resolution is achieved at the center of the FOV.
In the ideal system, resolution and sensitivity are constant through out the FOV. It is well
known that lines of response (LOR) in a real PET scanner have different sensitivity for
many reasons, such as solid angle subtended (Figure 3-2), intrinsic variation in detector
efficiency (e.g., variation in detector gain), detector penetration, septal absorption,
detector packing fraction , and event timing errors [23, 34]. Therefore, normalization
coefficients are applied to each LOR to minimize these factors. The direct normalization
method uses uniform activity cylindrical 68Ge volume source to measure the
normalization coefficients. Ideally, normalization removes sensitivity variations from the
data before image reconstruction.

Figure 3-2: Illustration of solid angle effects.
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The normalization method assumes that the normalization coefficients are
applicable to discrete sources, such as one finds for lesions in the clinical setting. This is
a critical assumption for accurate quantitative analysis. We scanned a 1 mL uniform
source over the FOV as a pilot study. The source was composed of 18F-FDG in a micro
centrifuge tubes. The result was surprising: recovered activity concentration varied with
location in the x-z plane (Figure 3-3). The recovered activity concentration varied by
36%. The next section describes an expanded experiment to further investigate this
problem.

Activity Concentration in the FOV
1000-1100
900-1000
Maximum
activity concentration
(Bq/mL)

800-900
700-800

6.25

600-700

4.25
-4.5

2.25
-1.5

-2.25
-4.25

1.5
-6.25

X-axis
patient's right is positive (cm)

4.5

Z-axis
positive toward
gantry (cm)

X-axis (cm)

Z-axis (cm)

4.5
1.5
-1.5
-4.5

6.25
1004
924
858
804

4.25
968
1041
880
903

2.25
959
780
927
818

-2.25
715
851
864
766

-4.25
833
671
685
855

-6.25
778
665
681
716

Figure 3-3: Variation of the measured activity concentrations as a function of location in
the FOV. The micro-centrifuge tube was scanned over a 6 x 4 grid. The maximum
activity concentration at each location was recorded. The table reports the activity
concentrations and the surface plot displays the results graphically.
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3.2.2 Materials and Method
Twenty-one micro-centrifuge tubes (inner diameter 9 mm; height 35 mm) were
arranged in a Styrofoam disk (diameter 20 cm, thickness 2.5 cm) as shown in Figure 3-4.
Each tube was arranged in a grid and separated by 4 cm.

18

F-FDG was prepared at the

concentration of 0.2 µCi/mL in a 50 mL volume, mixed well, and each tube was filled
completely with 1.7 mL of solution. The center of the disk was aligned to the center of
the FOV; the disk was scanned in the following orientations: X-Y (transverse), Y-Z
(sagittal), and Z-X (coronal) plane.

4 cm

4 cm

4 cm

Figure 3-4: Arrangement of the micro-centrifuge tubes. Twenty-one micro-centrifuge
tubes (inner diameter 9 mm; height: 35 mm) were placed in a Styrofoam disk (diameter
20 cm, thickness 2.5 cm). Each tube was arranged in a grid and separated by 4 cm. Each
tube contained 1.7 mL of 18F-FDG (0.2 µCi/mL).

The tubes were scanned using a clinical thoracic protocol (Thorax C-A-P + C).
The helical CT attenuation correction scan used a 1 mm slice thickness, an effective
current of 80 mA, and 130 kVp. Each PET scan was a 5 minute acquisition time with
one bed position. The image reconstruction used the default OSEM 4i8s and FORE
sinogram rebinning. Two reconstructed images with different matrix sizes (128 x 128
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and 512 x 512) were derived from the same data set. The maximum activity
concentrations of the objects were recorded from regions of interest drawn over all slices
of each object. We used the maximum value (instead of average) as used in the PET/CT
exam in the clinical setting.

3.2.3 Results and Discussion
Maximum activity concentration of each source in three planes is shown in Figure
3-5. For the X-Z and the Y-Z planes, the two outermost rows of tubes were not
completely visualized because they were located outside of the 15 cm axial FOV.
Consequently, maximum activity concentration values from these rows were not
measured. The average maximum activity concentrations with standard deviations are
given in Table 3-2. In Figure 3-5, the maximum activity concentration is plotted against
the coordinates of the different planes and displayed as a continuous surface. Neither
plane showed symmetry about the central X, Y, or Z axis (Figure 3-5). We wished to
acquire a blank scan to see if this gradient of the activity concentration was induced by
background radiation such as from the shielded cylindrical 68Ge source in the
examination room. However, we could not obtain a blank scan because of the clinical
scanning software would not allow image acquisition with no activity in the FOV. If the
room’s background is substantial, background subtraction from acquired data should be
used. In the future, one could scan a cylindrical 68Ge source and examine the activity
concentration profiles to see if this variation is introduced by the routine normalization
processes. As in indirect check of room background, we surveyed the PET examination
room with a survey meter (Biodex, Shirley, NY); the survey showed less than 100 cpm in
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the PET’s FOV. Thus, we expect that the background due to the 68Ge source in the room
is probably negligible.
Variations along the Z axis are less pronounced than along the X-axis and Y-axis
(Figure 3-5 A and Figure 3-5 B). In all planes, the 512 x 512 matrix produced less
variation than the 128 x 128 matrix reconstructions; however the pattern of variation did
not seem to be preserved. Variation in the plane is reduced by the larger matrix size for
the reconstruction algorithm. PET field of view is fixed. Increasing in matrix reduces
the size of each pixel (128 x 128 matrix 5.15 mm; 512 x 512 matrix 1.29 mm). The
sonogram matrix size is fixed by manufacturer. When the sonogram is converted into
128 x 128 matrix size in transaxial slices, it loses some information; the lower matrix grid
is too large relative to the size of the object.
There is an optimal number of iterations to obtain the best image. Too many
iterations can lead to noise amplification with deterioration in image quality [24]. We did
not examine the effect of iteration number within the scope of this thesis.
One potential source of variation is the FORE rebinning process.

Table 3-2: Acquisition and reconstruction parameters of CTI-Siemens Reveal-HD.
Matrix size
X-Z plane
Y-Z plane
X-Y plane

Average maximum activity
concentration (Bq/mL)
2766±438
2356±31
2919±362
2524±103
3526±647
2932±105

128 x 128
512 x 512
128 x 128
512 x 512
128 x 128
512 x 512
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Figure 3-5: Maximum activity concentration in three independent planes (A: X-Z, B:Y-Z,
C: X-Y). The maximum activity concentration of each object is plotted according to its
coordinate in the planes. Both 128x128 and 512x512 matrixes were investigated. The
curves in the 1-D plots represent the maximum concentration averaged in the orthogonal
direction to the plot axis. Error bars represent standard deviation of the averaged values.
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Sources placed in X-Y plane showed higher variation in activity concentration
compared to ones in X-Z and Y-Z plane. The reason of this is probably attributed to the
geometrical shape of the object. The X-Y plane produces the smallest transverse crosssection of the object among three planes because of the geometry of the micro-centrifuge
tubes. The partial volume effect that is discussed in Chapter 5 induces more errors in
activity concentration recovery in small objects. Imaging of spherical objects rather than
cylindrical tubes might be one way to minimize this effect; however such objects were
not available at the time of the experiments.
Although we demonstrated better activity concentration recovery with
OSEM4i8s in 512 x 512 matrix, in the clinical setting, a 128 x 128 matrix size is widely
used. For 128 x 128 matrix, it took 142 second to reconstruct images and for 512 x 512
matrix, it took 1251 sec. Our scanning was only for one PET bed. In a whole body PET
scan for an adult patient, six PET bed positions are typical. If the smaller matrix size is
the major factor inducing error in the uniformity across the FOV, then computation time
would be a part of the reason why our clinical mode is set to the lowest matrix size. If
the errors can be reduced by increasing matrix size, advancement of technology in
minimizing computation time should allow us to use higher matrix size in reconstruction.
We recommend using higher matrix size if we use PET data for quantitative purpose.
Another consideration that we should note is that we acquired images in air. To simulate
clinical situations, one should image the tubes in a cylindrical phantom filled with
physiological background 18F-FDG activity concentration. If we still see this nonuniformity for discrete sources under this setting, then calibrations for discrete source
objects may be necessary, instead of or after the manufacturer’s suggested normalization
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process. However, the normalization processes are done daily by manufacturer-created
routine QA software and we did not have access to data to understand what exactly this
software is doing for normalization. To conclude whether another discrete source
normalization process will improve accuracy of quantitation of the PET/CT scanner or
not, extensive collaboration with the manufacturer is probably necessary.
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Chapter 4
Contrast Agents and PET/CT Data

4.1 CT Numbers or Hounsfield Units (HU)
CT numbers are quantitative. CT numbers are used to identify the composition of
a structure or lesion such as lung or bone. After CT reconstruction, CT number
represents the relative attenuation coefficient of the tissue in that pixel, according to the
formula [32]
CT ( x, y ) = 1000 ×

( µ ( x, y ) − µ water )

(14)

µ water

CT numbers are called “Hounsfield units” (HU). The CT images typically possess 12
bits of values ranging from -1000 to +3095
(air: -1000, soft tissue: between -300 and -100, water: 0, dense bone: +3,000).
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4.2 Contrast Agents and Attenuation Correction
Factors
4.2.1 Introduction
The benefits from the administration of contrast agents are significant especially
in abdomen, pelvis, and head and neck studies. Oral contrast agents are widely
administered in most CT imaging because they help radiologists distinguish the
gastrointestinal tract mucosal surface from other tissue in CT images. Intra-venous (IV)
contrast agents are also widely administered for CT for more accurate identification of
vascular structures. Enhancement helps classification of lesions and also helps
delineation of pathological lesions from normal structures such as muscles and vascular
structures. Typical contrast agents are organic iodine (e.g., MD-Gastroview™ for oral
contrast and Ominpaque™ for IV contrast) and barium sulfate (oral and barium enema).
These agents are high atomic number materials; because of higher probability in
photoelectric absorption, they enhance x-ray attenuation and hence contrast in image
studies.
PET/CT studies are not an exception for use of contrast materials. PET/CT
obtains ACF’s from the CT scan. The method to obtain ACF’s in PET image requires a
step to convert attenuation coefficients at energies of 30 – 140 keV into 511 keV values
(Figure 4-1). The algorithm used in the CTI-Siemens PET/CT has a threshold at 300 HU
for converting either soft tissue or bone density. Therefore, high CT numbers caused by
contrast materials are interpreted as bone and can be scaled into a wrong ACF at 511 keV.
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Theoretically, these overcorrected values could possibly lead to false representations of
the PET images [35, 36].
The majority of patients undergoing PET/CT are oncological patients and it is not
infrequent for a patient to have a fluoroscopic study, receiving contrast agent for
screening for gastro-intestinal (GI) malignancies, prior to the PET/CT scanning.
Sometimes residual contrast agents in the GI tract are recognized after a topogram
(patient-positioning) scan during PET/CT studies. Fluoroscopic contrast causes
significant problems because a higher density of barium sulfate is used for these GI
radiographs.
In PET, the standard uptake value (SUV) is widely used to quantitatively
distinguish a malignant lesion from a benign lesion. The artifacts due to wrong HU
scaling by contrast agents possibly may mislead physicians’ interpretations of the
PET/CT image. To investigate the effect of contrast material on SUV, first we tested HU
for different dilutions of commonly used contrast materials. Second, we investigated its
effects on recovered activity concentration.
μ511 / µ70
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Figure 4-1: Plot of µ511/ µ70 as a function of HU. Scaling factors for soft tissue (water)
and bone are indicated by horizontal lines [1].

42

4.2.2 Materials and Methods
Three types of commercial contrast agents were investigated. They are barium
sulfate, oral iodine contrast, and IV iodine contrast.
Barium sulfate: Berry smoothie Readi-Cat 2™. Barium sulfate suspension 2.1% w/v (EZEM Inc. Westbuny, NY).
Oral iodine contrast: MD-Gastoview™. 367 mg/mL organically bound iodine. Diatrizoate
Megalumine and diatrizoate sodium solution (Mallinkrodt Inc. St.Louis, MO)
IV iodine contrast: Ominpaque 300™ Injection. 647.1 mg/mL inhexol solution; 300
mg/mL organically bound iodine (Amersham Health Inc. Princeton, NJ)

• Experiment 1
The following contrast materials were prepared in a series of dilutions in water as
follows: 0, 1, 2, 4, 10, 20, 30, 40, 50, 60, 70, 80, 90, and 100% (v/v) (100% means no
dilution). Ten milliliters of prepared contrast agents were placed into polyethylene
centrifuge tubes (1.5 cm inner diameter, 12 cm tall, and 15 mL capacity) and were
arranged in a Styrofoam rack as shown in Figure 4-2. The rack was centered in the FOV
of the PET/CT scanner using lasers. For each contrast material, to minimize the effect of
the location in the FOV, two scans were acquired: after the first scan, the rack was rotated
180 degrees and the second scan was obtained. CT images were obtained with the CTISiemens PET/CT scanners using the scanning parameter described in Chapter 3.
The images were analyzed using the scanner’s software. For each tube, circular
regions (37 pixels, 0.35 cm2 area) were drawn in three places, at the top, middle, and
bottom of each object, and the mean CT value for each region was recorded.
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• Experiment 2
Gastroview™ and Omnipaque 300™ were prepared in a series of dilutions of 0, 1,
4, 10, 20, 30, 40, 50, 60, 80, and 100% (v/v) as explained in Experiment 1.
A 1.0 mL volume of diluted contrast material was pipetted into 1.5 mL polyethylene
micro-centrifuge tubes (0.9 cm inner diameter), and arranged in a micro-centrifuge rack.
The tubes were arranged in columns spaced at 2.4 cm, 4.0 cm, and 5.6 cm from center of
the rack and FOV as illustrated in Figure 4-3.
A stock solution of 18F-FDG was prepared at the concentration of 109.6 µCi/mL. A 10
µL volume of 18F-FDG was pipetted into the 1 mL solution in each tube (1.1 µCi/mL).
Different contrast concentrations were arranged in the Z-direction because we know that
the variation of the measured activity concentration is less in this direction from the
experiment in section 3.1.2.
PET images were acquired on the Reveal HD scanner using the default Thoracic
protocol, except the slice thickness was set to 2 mm. The image data were viewed with
the PET/CT scanner software and the maximum pixel value of each object was recorded.
For comparison, images were also acquired using a GE Discovery ST PET/CT
scanner (The GE Discovery ST is owned by Mary Bird Perkins Cancer Center) in the
same experimental setting except the slice thickness was set to 3.75mm.
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Figure 4-2: Arrangement of 15 mL centrifuge tubes. The tubes were separated 4 cm
horizontally and 4.5 cm vertically. After the first scan, the arrangement was rotated 180
degree about the center of the FOV and a second scan was obtained. Numbers are
dilution in % as described in the materials and methods section.
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Figure 4-3: Arrangement of the micro centrifuge tubes. Numbers are dilution in % as
described in Materials and Methods. Centers of the vertical columns of tubes are 2.4 cm,
4.0 cm, and 5.6 cm from the FOV center. Each row was separated by 1.3 cm.
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4.2.3 Results and Discussions
• Experiment 1
Gastroview™ and Omnipaque 300™ demonstrated similar plots of CT values
(Figure 4-4). These contrast agents contain similar organic iodine concentrations. At
3071 HU, the CT values were saturated. This is due to computer memory of CT numbers
allocated, 12 bits. The typical clinical protocol uses 25 mL of Gastroview™ diluted into
240 mL of water. This yields approximately 10% on our dilution scale. The diluted
Gastroview™ is administered to the patient orally about 15-30 minutes prior to an
examination to allow the material to reach the pelvic bowel loop. For 2.1% barium
sulfate, the CT value was lower than either iodine contrast agent for all dilutions. At 10%
dilution for Gastroview™, the CT value was 822±22 HU. This is well above 300 HU
where a CT number’s segmentation algorithm has discontinuities, discussed in Chapter
2.2.2. The effect on the ACFs of barium sulfate, widely used in the clinical CT study,
likely is negligible, because all concentrations below 70% have CT numbers less than
300 HU. Therefore, we decided to investigate only the iodine contrast materials in
experiment 2.
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Figure 4-4: CT numbers in HU vs. concentration of contrast agents. As concentrations
of Gastroview and Omnipaque increase, CT number saturates at 3,071 HU, which is near
the maximum for 12 bits CT memory. The 2.1% barium sulfate dilutions span a smaller
range of CT numbers and did not saturated at high concentrations.
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• Experiment 2
The F-18 activity concentration as a function of contrast concentration is shown in
Figure 4-5. For CTI/Siemens scanner, the largest error in average maximum activity
concentration was seen at the highest dilution (80%). Activity concentration was
overestimated 59% for Gastroview™ and 39% for Omnipaque 300™ at 80% dilution. At
10% dilution, the error was 19% and 7% respectively. At 10% dilution for Gastroview™,
the clinical dose given to patient, the error in recovery in activity concentration may not
be negligible. These data are consistent with our results described in Chapter 3:
recovered activity concentrations are a function of position in the FOV. There are
published articles using phantoms regarding contrast materials and activity concentration
recoveries [17]; however no article has mentioned this variation of the activity
concentration in the FOV. For a phantom study, we think radioactive materials in the
FOV need to be carefully arranged to account for this variation. One problem that we did
not consider at this point was distance between each row of micro-centrifuge tubes. Each
row was only separated by 1.3 cm; we cannot rule out that the PET scanner resolution
may cause the tube’s image to overlap, altering the apparent maximum intensities. We
investigate this issue in Chapter 5.
We also tested a different scanner (GE). The Discovery ST is a BGO based
system (6 mm x 6 mm BGO crystals) which is larger than CTI-Siemens BGO crystals (4
mm x 4 mm)
Errors were as follows. Gastroview™: 26% for largest error at 60% dilution, 12% error
for 10% dilution. Omnipaque™: 13% for largest error at 60% dilution, 5% error for 10%
dilution. The GE system had less maximum error. The reason why 60% not 80%
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dilution produced maximum error is unknown. We did not measure the variation of
activity concentration across the FOV for this scanner. The GE scanner uses septa to
acquire 2D mode data, unlike the Reveal scanner. With the different concentrations
arranged in the axial direction of the gantry, it is possible that subtle differences in the
position of objects in relation to the septa affect the potential sensitivity. Further
investigation of the GE scanner was viewed as an extension to the primary purpose of
this thesis. In the future one should investigate the effect of 2D vs. 3D acquisition modes
on system response uniformity. The GE scanner is capable of retracting its septa to
acquire data in 3D mode, so it would be an ideal platform for further investigation.
A recent clinical study reported that the PET artifact by an intravenous contrast
material was limited to the thoracic veins containing undiluted contrast agent [36]. They
also found that patients with artificially high uptake values have statistically smaller body
surface area than patients with no artifacts. Another possible cause of artifacts is that
bolus IV contrast passages are imaged in the CT scan but when the PET data are acquired
subsequently, the high concentration of the contrast materials has redistributed
throughout the body.
Another group reported that high density barium oral contrast used for some GI
studies can potentially overcorrect ACFs, but the low density agent typically used for CT
has negligible effects [37].
One group has investigated changes in contrast agent density with location in the
GI tract. Their study used 3% gastrographin (equivalent to Gastroview) and 1.5%
barium sulfate. As the oral contrast agent goes down the GI tract, the density increased:
gastrographin from 143 ± 37 HU in stomach to 243 ± 43 HU in ileum; barium from
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171±45 HU in stomach to 263±24 HU in ileum. They demonstrated overestimation of
activity concentrations (for gastrographin 20%; barium 21%). For 50% dilution of
barium, a typical concentration used in colonography, the over-estimation of activity
concentration was 580% [38].
These studies indicated that if the administered volume of intravenous contrast
material is corrected according to body surface area of the patient, the effect on ACFs is
negligible. Barium contrast materials for gastrointestinal radiography (such as barium
enema) may adversely affect ACFs for PET imaging.
Another study compared recovered activity concentrations in different organs for
Ge-68 based and CT-based ACFs [39]. CT-corrected emission images showed slightly
higher radioactivity concentration values for all malignant lesions and all normal organs
except lung (mean 4.3% and maximum 15.2% higher). This indicates that comparison of
quantitative analysis between different ACF correction methods has to be careful; one
must be careful comparing SUV values among different scanners.
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Figure 4-5: Measured activity concentration as a function of concentration of contrast
agents. Two different scanners are compared (A: CTI/Siemens Reveal and B: GE
Discovery). Activity concentrations for three individual distances from the center and
average activity concentrations are demonstrated.
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Chapter 5
Recovery of Radioactivity Concentrations
of Small Spheres

5.1 Object Size and Radioactivity Concentration
5.1.1 Motivation
• Quantitative Analysis in Oncology
The beneficial use of the PET/CT scanner is already demonstrated in management
of oncological patients in many studies. 18F-FDG PET has a major impact on the
management of patients with small lung cell cancer; in 29% of patients both the stage and
the management was influenced by the PET results. Accurate quantitation of small
lesions is especially important for diagnosis.
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• Partial Volume Effect
In ideal quantitative PET, the image should represent the distribution of
radioactive tracer concentration as a size-invariant function. Partial volume effect causes
a small object, less than twice the spatial resolution of the imaging system, to have
reduced signal amplitude [18, 23, 40]. This effect has been widely addressed in brain
research where quantitative analysis of small areas of abnormal cortex within normal
tissue is critical. If object size affects accuracy of tracer activity concentration recovery,
we need to know the limitation of the method in an oncological setting. An inaccurate
recovery of small lesions affects diagnosis and evaluation of the malignant lesions.
Surprisingly, partial volume effects are not widely discussed in textbooks or review
articles related to diagnosis of malignancy using PET/CT. Little information was found
in the literature about the influence of partial volume effect on maximum pixel value
measurements, such as one uses in clinical settings to calculate SUV. We tested several
different sizes of spheres and sought to identify the critical object size that results in
significant error in recovered activity concentration for diagnosis in the oncological
setting.

5.1.2 Materials and Methods
A 0.4 µCi/mL (14800 Bq/mL) activity concentration of 18F-FDG was prepared in
a volume of 50 mL water. Four different diameters of plastic spheres (10 mm, 14 mm, 18
mm, and 23 mm inner diameters) were arranged on a 6 cm radius circle on the scanner’s
X-Z plane. The objects’ centers were evenly spaced. For each diameter, three identical
sizes of spheres, except for the largest 23 mm sphere, were arranged alternately and two
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scans were obtained, by rotating 60 degrees around the center for each scan to minimize
the effect of the location in the FOV which we discussed in Chapter 3. The routine
thoracic protocol explained in the previous chapter was selected for scanning. The CT
was set to 80 mA, 130 kV, and 1.0 mm slice thickness. The PET data was acquired in
one PET bed for 5 minutes. The OSEM 4i8s with 128 x 128 matrix was used to
reconstruct images. The maximum activity concentration (Bq/mL) of the objects in each
reconstructed image was recorded. The average value was calculated from each size and
the two scans.

5.1.3 Results and Discussions
The results indicate that the activity concentration error is larger, when the object
diameter is smaller. The largest error of activity concentration was observed in the 10
mm sphere, which gave 46% of activity concentration of the largest sphere, as shown in
Figure 5-1. The 1.4 cm sphere showed 85% of the recovered activity of the 2.3 cm
sphere and the 1.8 cm sphere gave 97%. The 2.3 cm sphere gave an activity
concentration of 4387 Bq/mL, compared to the expected value of 14800 Bq/mL. This
error increases drastically for lesions less than 1.5 cm. The FWHM of the PET/CT
scanner is approximately 7 mm. As previous publications indicated, objects less than
twice the FWHM produce significant error in the activity concentration [18].
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Figure 5-1: Maximum activity concentration as a function of sphere diameter. The 1.0
cm sphere recovered an activity only 46% of that recovered by the 2.3 cm sphere. Sphere
less than ~1.4 cm diameter exhibit more error than larger spheres. The error bars
represent standard deviation of the average of the two scans and the three spheres of each
size.
According to the results, correction factors are required according to the object’s
size. In PET in the experimental setting, the sizes of the objects are known prior to
scanning. In clinical settings, we do not know the size of the lesion in advance. However,
to recover a correct activity concentration, we need an estimation of the object size.
One approach is to use another imaging method, such as MRI or CT, to estimate object
size. Unfortunately, small lesions may not be visible on either of these imaging methods
in real practice. Some lesions visible on PET are not visible for other imaging methods.
In that case, there is no way to recover the size of the object other than from PET data
itself.
In an ideal situation, if the object has uniform radioactivity uptake in the lesion
and if we know the point spread function of the PET image, by deconvolving the PSF
from the image, we can theoretically recover an activity distribution map in the body.
If the lesion is visible on CT, then PET/CT has an advantage: the object size is
available in CT data sets. Problems arise however. (1) Even normal tissue in organs
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does not guarantee uniform activity distribution across patients, because there are
variations among individuals. (2) Malignant lesion’s uptake is not uniform for 18F-FDG
as we discussed in Chapter 1. Uptake reflects hypoxic cells and there are variations in
uptake even within a single malignant lesion.
A literature search revealed an article discussing recovery of sphere objects [41].
Accurate quantitation of small lesions requires correction for the partial volume effects.
This correction factor is called recovery coefficient (RC), and depends on the lesion size,
the object-to-background ratio, and the physical properties of the object. Several
approaches have been proposed to correct for partial volume effects [18, 40-42].

5.2 Radioactivity Concentration Recovery of
Multiple Objects
5.2.1 Background
In the last section, we investigated the recovery size for a single object. Next, we
investigated distances between objects for recovery of activity concentrations.
Malignant lesions such as lymph node metastasis are sometimes located next to each
other. Suppose we have recovered the correct activity concentration according to the
object sizes, we still do not know if the distance between objects affects the recovery of
activity concentrations.
If we place a true point source, in an ideal imaging system, the activity
concentration in the image is registered as a delta function or a peak only in one pixel.
However, in a real imaging system, there is a finite spread of the values. An observed
image is a point spread function convolved with the distribution of the activity source.
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One can imagine as two objects get close to each other, the activity concentration
distributions overlap and alter the recovered values.
We chose spheres because lesions that we are interested in such as lymph nodes
are generally spherical. We have tested two different sizes of three identical spheres
separated in five different positions. We have also compared OSEM reconstruction to
FBP reconstruction. FBP is important not only because it has minimal computational
time compared to iterative algorithms, but also it is a linear analytical algorithm, ideally
providing better control of the spatial resolution and noise reduction, a control necessary
for quantitative data analysis [23]. We tested the FBP algorithm in different matrix sizes,
and compared to OSEM to see if FBP provides more accurate activity concentration
recoveries.

5.2.2 Materials and Methods
• Experiment 1
Three identical sizes of plastic spheres (10 mm and 18 mm inner diameter; 1 mm
wall thickness) were aligned on the X axis at the center of the FOV. Outer walls of the
three spheres were separated by 0 mm, 5 mm, 10 mm, 15 mm, and 20 mm (Figure 5-2)
and data were acquired using the CTI-Siemens PET/CT scanner as described in Chapter 3.
The activity concentration was 0.2 µCi/mL (7400 Bq/mL) and the scans used the Thorax
C-A-P + C protocol. The default reconstruction algorithm (OSEM 4i8s, FORE, 128 x
128 matrix) was used to reconstruct images. Attenuation uncorrected image files
formatted in DICOM was analyzed using IDL 5.6 student edition (Research System Inc.,
Boulder, CO). For each transaxial slice, each column was searched for the maximum
pixel number and multiplied by the rescaling slope found in the DICOM file to create
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maximum activity concentration profiles. The slices with the maximum activity
concentration were identified. The maximum activity concentration was analyzed as a
function of position in the image profiles.

• Experiment 2
Three spheres were positioned at the center of FOV along the X-axis. We only
tested the 10 mm sphere because we already know that the 18 mm sphere gives relatively
accurate recovery of activity concentration from Experiment 2 of Chapter 5.1. Three
identical 10 mm plastic spheres were aligned on the X axis at the center of FOV. The
outer walls of the spheres were separated by 0 mm and images were acquired with the
CTI-Siemens PET/CT scanner as described in Chapter 3. The activity concentration was
0.2 µCi/mL (7400 Bq/mL). The same raw data were reconstructed three different ways
into images. The methods were (a) OSEM 4i8s, FORE, 128 x 128 matrix; (b) FBP with
Gaussian filter with 3mm FWHM, 128 x 128matrix; (c) FBP with Gaussian filter with
3mm FWHM, 512 x 512 matrix. Attenuation uncorrected image files formatted in
DICOM were analyzed using IDL 5.6 student edition (Research System Inc., Boulder,
CO). For each transaxial slice, each column was searched for the maximum pixel
number to created image profiles. All trans-axial slices were examined and the slice that
gave the maximum pixel numbers was selected and multiplied by the rescaling slope
found in the DICOM file to calculate maximum activity concentration. Activity
concentrations were analyzed as a function of position across the scanner FOV.
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Figure 5-2: Arrangement of three identical hollow spheres. The separations of the
objects were measure in separation of outer walls. The center sphere was located at the
center of FOV. The three balls were arranged in tandem along the X-axis.

5.2.3 Results and Discussion
• Experiment 1
The results are shown in Figure 5-3. Variations in maximum activity
concentrations were greater in 10 mm spheres than in 18mm spheres. This is probably
due to the partial volume effect that we discussed previously. For a small object, only a
small number of pixels compose its image, possibly introducing significant errors in
recovery of activity concentrations. The locations of small objects relative to the pixel
grid might have a large effect. Some of the variation may also be due to the locationdependent variation in uniformity described in Chapter 3. All recovered activities were
less that the values prepared (7400 Bq/mL). Errors are possibly attributed to
normalization process of the PET/CT scanner or dose calibration error using well counter.
We did not investigate the cause of the errors at the time of experiment.
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Overlaps of the images of the spheres are not as great as we expected; the amount
of overlap is indicated by the profiles not reaching a value of zero. At 10 mm separation,
the objects do not overlap. This is consistent with the PET resolution of 7 mm FWHM.

• Experiment 2
Figure 5-4 shows the results for the three different reconstruction methods. Our
results indicate that increasing matrix size for FBP improves the recovery of maximum
activity concentrations for the three spheres. Increased matrix size has a smoothing effect
on objects (Figure 5-4). This is consistent with the results in Chapter 3 testing different
matrix size with OSEM. An increase in matrix size improved the recovery of activity
concentrations. We used the same raw data to reconstruct images using the three
different methods. Calibrated activity concentration was 0.2 µCi/mL (7400 Bq/mL). The
maximum activity concentrations were highest in OSEM 128 x 128 among all three
algorithms; however it still has lower activity concentration than calibrated values. This
indicates that recovered activity concentrations were not quite accurate for any method.
Among the three reconstruction algorithms, 512 x 512 FBP gave less variation in
maximum activity concentrations. 128 x 128 FBP gave the smallest activity concentration
values. The discrepancies observed in all experiments between calibrated and recovered
activity concentrations could be due to calibration errors in the well counter when
measuring a small activity source. Likewise, scaling errors from counts per pixel to
activity concentrations by the PET/CT scanner software also could cause the observed
discrepancies.
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Figure 5-3: Profiles of maximum activity concentrations of three spheres arranged in
tandem. 10 mm and 18 mm diameter spheres were tested. Outer walls of spheres were
separated 0, 5, 10, 15, and 20 mm. Maximum pixel values were searched in Y-direction
and activity concentrations were plotted a function of position along the X-axis.
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Figure 5-4: Maximum activity concentration recovery for three spheres arranged in
tandem are plotted as a function of position in X-direction. Three different image
reconstructions were tested on the same raw data. A: OSEM 4i8s 128 x 128matrix, B:
FBP 128 x 128 matrix, and C: FBP 512 x 512 matrix. Outer walls of the spheres are
spaced without any gap.
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Chapter 6
Conclusions

In Chapter 3, we demonstrated that the currently available clinical PET/CT
scanner does not guarantee accurate recoveries of activity concentrations with clinical
scanning modes. The normalization process of the PET scanner using a continuous
volume source does not lead to an accurate normalization of discrete small sources in the
FOV. Also the image reconstruction parameters should be optimized by further
investigations.
In Chapter 4, we tested one of the possible factors, contrast agents, that might
affect quantitation of the PET/CT data. The iodine-based oral and intravenous contrast
agents we tested seem to be in the range where the effects on attenuation correction
factors may be negligible, except for some particular conditions discussed in that Chapter.
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In Chapter 5, we demonstrated that the size of the objects affects activity
concentrations; errors are not negligible for small objects less than twice the FWHM of
the PET scanner. To use PET/CT as a quantitative method, an algorithm that corrects for
object size variation is probably necessary. However, obtaining an accurate estimate of
object size can be difficult in clinical situations. Our multiple lesion model using three
spheres demonstrated the major issue is their sizes rather than separation between objects,
probably because of partial volume effects. Increasing the matrix size of the
reconstructed image improved the PET/CT scanner’s quantitative accuracy. Immediate
possible improvement of clinical PET/CT scanner is to increase matrix size of
reconstruction for quantitaion purpose. . Another solution is to improve PET scanners’
resolution, thereby reducing partial volume effects
A question thus arises: Suppose we could overcome all technical difficulties of
recovering the activity concentration. We are still dealing with many factors involved in
calculation of SUV’s, such as variation in metabolism of 18F-FDG among patients and
variation in time elapsed between injections and scanning (although the scanners decaycorrect the image data, count statistics will change). Consequently, is SUV the best
choice?
It seems to be more reasonable to use an average uptake value of the organ which
is unique to an individual patient and an individual scanner to distinguish malignant
lesions from benign lesions. One possible calculation is

Ratio =

Lesion [ Bq / mL]
Average Organ [ Bq / mL]

(15)

Lesion : Activity concentration of the region of interest
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Average Organ : Average activity concentration of all pixels in the
specified organ

Delineation of organs and ROIs is labor-intensive. The development of automated
segmentation algorithms would be helpful for this task.
A similar approach has been used in radiology. A CT scan data set has gray scale
values in HU. For diagnosing different lesions in different organs, radiologists will
typically look at three sets of images: bone window, soft tissue window, and lung
window. The CT value is a representation of a physical property (attenuation
coefficients) unique to each tissue type. These windows can be optimized manually by
the radiologist; the optimal bone window may be different in health young individuals as
opposed to an older individual with osteoporosis. However, each window does not vary
greatly among individuals.
In 18F-FDG PET, an analogous window approach is not possible. This is due to
18

F-FDG uptake reflecting both normal tissue and tumor physiology. The distribution of

activity concentration varies from patient to patient. Given the activity concentrations of
individual pixels, one cannot conclude if it is normal tissue or a malignant lesion.
However, SUV value is essentially taking this approach for every patient; only the
absolute magnitude is considered, rather than the magnitude in relation to surrounding
organs. SUV certainly works if we have a highly-specific radioactive tracer, which
exhibits no uptake in normal tissue. However 18F-FDG PET with current instrumental
limitations of PET scanners may not provide useful SUV values.
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Well experienced nuclear medicine physicians do threholding manually to
optimize display windows and they should carefully examine both attenuation-corrected
and uncorrected images to visualize the lesions (Figure 6-1). However, this requires a lot
of experience; a majority of physicians may not be aware of the importance of
thresholding necessary for accurate diagnosis and may overlook some lesions. With the
current PET/CT, with CT images’ anatomical information, one can delineate organs and
ROIs. CT-based delineation may help with the calculation of equation (12) and may also
help to select a proper PET window. Then by comparing the activity concentration in
ROI with the background concentration in particular organs, we can establish more
accurate information about the lesions.

Our conclusion is: Although 18F-FDG based PET/CT scanners have great
advantages in radiation therapy, particularly for detecting radiotherapy-resistant hypoxic
lesions, the currently available scanners are not completely satisfactory for strict
quantitative analysis. Developing methods to calculate recovery coefficients for discrete
sources according to size and uptake is essential to assure the quantitative quality of
PET/CT in oncology settings. The development of parameters other than SUV may
overcome SUV’s inherent limitations reflecting the patient physiology and the scanner
characteristics. We suggest that an individual organ-based PET activity concentration
scale may provide for more accurate quantitation in PET/CT.
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Uncorrected
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D

A

B

E

F
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Figure 6-1: An example of the importance in optimizing display windows of both
attenuation-corrected and uncorrected image sets to visualize a lesion. A-C: attenuation
uncorrected image, D-F: attenuation corrected image. A lesion is visible on A, but not on
D. B and E are transaxial fused PET/CT images. The lesion is easily detected on B.
Only optimal windowing will allow physicians to visualize the lesion on E. C and F are
transaxial CT images. The lesion is not easy to evaluate from CT images only (Courtesy
of Steven Bujenovic, M.D.).
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